Headlines

Bausch Might Sell Eyecare Business, Bloomberg Reports

The Bausch + Lomb brand sells products such as contact lenses and surgical devices.

Published

3 years ago

May 2, 2021

Bausch Health is considering selling its eyecare business, according to a news report.

The Bausch + Lomb brand sells products such as contact lenses and surgical devices. Private equity units and other potential buyers have shown interest in the unit, Bloomberg reports, citing unnamed sources.

There’s no final decision yet. Other options under consideration include holding on to the business or spinning it off, according to Bloomberg.

A Bausch Health representative declined to comment, Bloomberg reports.

In August 2020, Bausch Health Cos. Inc. said it planned to spin off its eye health business into an independent publicly traded company called Bausch + Lomb – NewCo. The spinoff was to establish two separate companies:

Bausch + Lomb – NewCo, an eye health company built on the Bausch + Lomb brand.
BHC, a diversified pharmaceutical company with leading positions in gastroenterology, aesthetics/dermatology, neurology and international pharmaceuticals.

Read more at Bloomberg

The Best Overall Progressive Lens, Now Powered by AI

Engineered with Behavioral Artificial Intelligence and utilizing new XR-motion™ technology, Varilux XR series goes beyond prescription and eye physiology to consider the patient’s visual behavior and design a progressive lens that respects how
their eyes naturally move.

Varilux XR series comes in two versions, Varilux® XR design and Varilux® XR track. The Varilux XR track lens provides an additional level of personalization by incorporating the exclusive Near Vision Behavior Measurement, providing up to 25% more near vision width³ according to the patient’s need, so patients get the highest level of customization.

Discover Varilux XR series and enjoy instantly sharp vision in motion⁴ and seamless transitions from near to far.

For more information, visit here.